Literature DB >> 2867824

Expression of tissue transglutaminase in cultured monocytic leukemia (THP-1) cells during differentiation.

K Mehta, G Lopez-Berestein.   

Abstract

Retinoic acid (RA) and 12-O-tetradecanoyl-phorbol-13-acetate (TPA) induced differentiation of a human monocytic leukemia cell line, THP-1. RA- or TPA-treated cells stopped proliferating, became adherent to plastic surfaces, and acquired the ability to phagocytose yeast cells, plain sheep RBCs, and IgG-coated sheep RBCs. The morphological and functional changes, induced by RA or TPA, were associated with a 20-50-fold increase in cellular transglutaminase activity. This increase in enzyme activity was found to be due to the induction of a specific intracellular transglutaminase, tissue transglutaminase. The induction of tissue transglutaminase was a specific response of THP-1 cells to differentiation and was not observed with agents that did not induce their morphological or functional differentiation. Dibutyryl cyclic AMP potentiated the RA-induced expression of tissue transglutaminase. A 15-min exposure to TPA was sufficient to induce differentiation and expression of tissue transglutaminase in THP-1 cells. In contrast, RA required a continuous exposure (48 h) to induce similar changes in morphology or enzyme activity. These results support the view that differentiation of cells of the monocytic lineage is associated with an induction and accumulation of the protein cross-linking enzyme tissue transglutaminase.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2867824

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Retinoic acid-induced modulation of rat liver transglutaminase and total polyamines in vivo.

Authors:  M Piacentini; L Fesus; C Sartori; M P Ceru
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

2.  A novel mechanism by which tissue transglutaminase activates signaling events that promote cell survival.

Authors:  Lindsey K Boroughs; Marc A Antonyak; Richard A Cerione
Journal:  J Biol Chem       Date:  2014-02-25       Impact factor: 5.157

3.  Bovine aortic endothelial cell transglutaminase. Enzyme characterization and regulation of activity.

Authors:  G Korner; D E Schneider; M A Purdon; T D Bjornsson
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

4.  Positional cloning and next-generation sequencing identified a TGM6 mutation in a large Chinese pedigree with acute myeloid leukaemia.

Authors:  Li-Li Pan; Yuan-mao Huang; Min Wang; Xiao-e Zhuang; Dong-feng Luo; Shi-cheng Guo; Zhi-shun Zhang; Qing Huang; Sheng-long Lin; Shao-yuan Wang
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

5.  The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.

Authors:  Garima Singh; Jingwen Zhang; Yilun Ma; Richard A Cerione; Marc A Antonyak
Journal:  J Biol Chem       Date:  2016-02-18       Impact factor: 5.157

6.  "Differentiation Induction" culture of human leukemic myeloid cells stimulates high production of macrophage differentiation inducing factor.

Authors:  T Abe; M Ohno; T Sato; M Murakami; M Kajiki; R Kodaira
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

7.  Hepatitis B virus differentially suppresses myelopoiesis and displays tropism for immature hematopoietic cells.

Authors:  G K Sing; S Prior; A Fernan; G Cooksley
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

8.  Identification of a cell-type-specific and E2F-independent mechanism for repression of cdc2 transcription.

Authors:  J L Sugarman; A H Schönthal; C K Glass
Journal:  Mol Cell Biol       Date:  1995-06       Impact factor: 4.272

9.  Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma.

Authors:  P E Newburger; R A Ezekowitz; C Whitney; J Wright; S H Orkin
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Bisphosphonates inhibit stellate cell activity and enhance antitumor effects of nanoparticle albumin-bound paclitaxel in pancreatic ductal adenocarcinoma.

Authors:  Vianey Gonzalez-Villasana; Cristian Rodriguez-Aguayo; Thiruvengadam Arumugam; Zobeida Cruz-Monserrate; Enrique Fuentes-Mattei; Defeng Deng; Rosa F Hwang; Huamin Wang; Cristina Ivan; Raul Joshua Garza; Evan Cohen; Hui Gao; Guillermo N Armaiz-Pena; Paloma Del C Monroig-Bosque; Bincy Philip; Mohammed H Rashed; Burcu Aslan; Mumin Alper Erdogan; Yolanda Gutierrez-Puente; Bulent Ozpolat; James M Reuben; Anil K Sood; Craig Logsdon; Gabriel Lopez-Berestein
Journal:  Mol Cancer Ther       Date:  2014-09-05       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.